A new biotech production and training facility opened by the University of Technology Sydney (UTS) will help address local biotech skills shortages, it is hoped.

The Biologicals Innovation Facility (BIF), launched by UTS, the NSW government and GE Healthcare includes clean rooms and containment laboratories which will house research and development.

UTS students will have access to the facility, as will Australian businesses seeking to pilot and test products.

Professor Attila Brungs, vice chancellor of UTS, said the facility will bring a range of benefits to the Australian health and biotech sectors.

“I expect this facility will be key to addressing local skills shortages and ensuring the brightest and most talented scientists and engineers stay locally, allowing Australia to capture a multibillion dollar share of a rapidly expanding biologics market while also making real world impact in the area of biologics,” said Brungs.

UTS dean of science, Professor Dianne Jolley, said the facility would boost Australia’s reputation for biotech innovation across the globe.

“Australian-made pharmaceuticals and nutraceuticals enjoy a reputation for quality, traceability and trust and this innovative facility will help keep Australia globally competitive,” said Jolley.

The $11.5 million facility was supported by $750,000 from the NSW Boosting Business Innovation Program and $1.2m from the National Collaborative Research infrastructure Strategy.

This content does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.